E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers G > Headlines for Generex Biotechnology Corp. > News item
Published on 11/15/2005 in the Prospect News Biotech Daily.

Generex back in compliance with Nasdaq standards

New York, Nov. 15 - Generex Biotechnology Corp. said it has received written confirmation from the Nasdaq Stock Market that it is back in compliance with the listing requirements.

Generex is a Toronto-based company researching drug delivery systems and technologies.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.